Kemira president and CEO Jari Rosendal died after a short illness on 31 July. He was 58. The company had announced that he had gone on sick leave on 11 July and a week later said that he would step down by 2024 at the latest. CFO Petri Castrén is acting as interim president and CEO while a successor is sought.
Kemira and its pension fund, Neliapila, have signed a pre-agreement and lease agreement with a consortium of Ahlström Capital, Kirkon Eläkerahasto and Aktia Life Insurance. Under this, they will build a new research centre for Kemira as part of the Green Chemistry Park within a 5.5-hectare site at Espoo, near Helsinki in Finland.